NATERA INC (NTRA) Stock Price, Quote, News and Overview
NASDAQ:NTRA - Nasdaq - US6323071042 - Common Stock - Currency: USD
NTRA Quote, Performance and Key Statistics
NASDAQ:NTRA (2/24/2025, 1:53:59 PM)
161.335
-0.97 (-0.6%)
The current stock price of NTRA is 161.335 USD. In the past month the price decreased by -5.53%. In the past year, price increased by 130.36%.
NTRA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 20.24 | 361.87B | ||
| AMGN | AMGEN INC | 15.62 | 166.26B | ||
| GILD | GILEAD SCIENCES INC | 24.16 | 138.78B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1659.83 | 123.66B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.53 | 77.50B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.49B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.03B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.67B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.9 | 16.16B | ||
| INSM | INSMED INC | N/A | 14.61B |
Related stock screener links
About NTRA
Company Profile
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. The company is headquartered in Austin, Texas and currently employs 3,282 full-time employees. The company went IPO on 2015-07-02. Its cell-free deoxyribonucleic acid (cfDNA) technology combines its molecular assays, which reliably measure many informative regions across the genome from samples as small as a single cell. The firm's product offerings include Panorama Non-Invasive Prenatal Test (NIPT), Vistara, Horizon Carrier Screening, Spectrum Preimplantation Genetics, Anora Miscarriage Test, Empower, and Prospera. The firm also offers Constellation, a cloud-based software platform that enables laboratory customers to gain access through the cloud to the Company’s algorithms and bioinformatics in order to validate and launch tests based on the Company’s technology. Its NIPT screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother.
Company Info
NATERA INC
13011 Mccallen Pass, Building A Suite 100
Austin TEXAS 78753 US
CEO: Steve Chapman
Employees: 3288
Company Website: https://www.natera.com/
Investor Relations: https://investor.natera.com
Phone: 16502499090
NATERA INC / NTRA FAQ
What is the stock price of NATERA INC today?
The current stock price of NTRA is 161.335 USD. The price decreased by -0.6% in the last trading session.
What is the ticker symbol for NATERA INC stock?
The exchange symbol of NATERA INC is NTRA and it is listed on the Nasdaq exchange.
On which exchange is NTRA stock listed?
NTRA stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for NATERA INC stock?
27 analysts have analysed NTRA and the average price target is 192.97 USD. This implies a price increase of 19.61% is expected in the next year compared to the current price of 161.335. Check the NATERA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is NATERA INC worth?
NATERA INC (NTRA) has a market capitalization of 21.30B USD. This makes NTRA a Large Cap stock.
How many employees does NATERA INC have?
NATERA INC (NTRA) currently has 3288 employees.
What are the support and resistance levels for NATERA INC (NTRA) stock?
NATERA INC (NTRA) has a support level at 162.3 and a resistance level at 168.08. Check the full technical report for a detailed analysis of NTRA support and resistance levels.
Is NATERA INC (NTRA) expected to grow?
The Revenue of NATERA INC (NTRA) is expected to grow by 56.77% in the next year. Check the estimates tab for more information on the NTRA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NATERA INC (NTRA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NTRA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NTRA, evaluating the profitability, health, valuation and growth aspects
- NATERA INC (NTRA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NATERA INC (NTRA) Sales and EPS estimates to see what analysts future expectations are.
- NATERA INC (NTRA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NATERA INC (NTRA) Insider and Institutional Ownership to learn about the owners and their transactions.
- NATERA INC (NTRA) Stock Chart to make your own analysis
- NATERA INC (NTRA) Latest news and press-releases to stay up to date.
Does NATERA INC (NTRA) stock pay dividends?
NTRA does not pay a dividend.
When does NATERA INC (NTRA) report earnings?
NATERA INC (NTRA) will report earnings on 2025-02-27, after the market close.
What is the Price/Earnings (PE) ratio of NATERA INC (NTRA)?
NATERA INC (NTRA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.76).
What is the Short Interest ratio of NATERA INC (NTRA) stock?
The outstanding short interest for NATERA INC (NTRA) is 3.53% of its float. Check the ownership tab for more information on the NTRA short interest.
NTRA Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to NTRA. When comparing the yearly performance of all stocks, NTRA is one of the better performing stocks in the market, outperforming 95.65% of all stocks.
NTRA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to NTRA. NTRA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
NTRA Financial Highlights
Over the last trailing twelve months NTRA reported a non-GAAP Earnings per Share(EPS) of -1.76. The EPS increased by 61.06% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -13.49% | ||
| ROE | -24.44% | ||
| Debt/Equity | 0.42 |
NTRA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 85% to NTRA. The Buy consensus is the average rating of analysts ratings from 27 analysts.
For the next year, analysts expect an EPS growth of 59.52% and a revenue growth 56.77% for NTRA